Form 4: Organogenesis Holdings Inc. Executive Patrick Bilbo Reports Stock Transaction
SEC Form 4 Filing
Patrick Bilbo, Chief Operating Officer of Organogenesis Holdings Inc., reports disposition of shares to cover tax obligations.
Summary
- On April 1, 2024, Patrick Bilbo, the Chief Operating Officer of Organogenesis Holdings Inc., reported a transaction involving Class A Common Stock.
- Bilbo disposed of 2,497 shares at a price of $2.8 per share to cover tax obligations.
- Following the transaction, Bilbo directly owns 809,082 shares of Class A Common Stock.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing reporting a routine stock transaction. It doesn't inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure related to executive stock transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company insiders.
Stakeholder Impact
- The transaction is unlikely to have a significant impact on stakeholders as it is a routine sale of shares by an executive to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| 04/01/2024 | Date of stock transaction |
| 04/03/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.